Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Other Accumulated Expenses: 2016-2024

Historic Other Accumulated Expenses for Fortress Biotech (FBIO) over the last 6 years, with Dec 2024 value amounting to $1.5 million.

  • Fortress Biotech's Other Accumulated Expenses fell 86.99% to $135,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $135,000, marking a year-over-year decrease of 86.99%. This contributed to the annual value of $1.5 million for FY2024, which is 822.70% up from last year.
  • Per Fortress Biotech's latest filing, its Other Accumulated Expenses stood at $1.5 million for FY2024, which was up 822.70% from $163,000 recorded in FY2023.
  • Fortress Biotech's Other Accumulated Expenses' 5-year high stood at $5.3 million during FY2020, with a 5-year trough of $163,000 in FY2023.
  • In the last 3 years, Fortress Biotech's Other Accumulated Expenses had a median value of $996,000 in 2022 and averaged $887,667.
  • As far as peak fluctuations go, Fortress Biotech's Other Accumulated Expenses crashed by 83.63% in 2023, and later skyrocketed by 822.70% in 2024.
  • Fortress Biotech's Other Accumulated Expenses (Yearly) stood at $5.3 million in 2020, then reached $996,000 in 2022, then plummeted by 83.63% to $163,000 in 2023, then skyrocketed by 822.70% to $1.5 million in 2024.